Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents

Goñi Esarte, Silvia; Juanbeltz, Regina; Zozaya, José Manuel; Úriz, Juan Isidro; Castilla, Jesús; Herrero, José Ignacio.
Gastroenterol. hepatol. (Ed. impr.) ; 43(5): 248-255, mayo 2020. tab, graf
Artigo em Inglês | IBECS (Espanha) | ID: ibc-193001

Documentos relacionados

  1. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents.
  2. Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment.
  3. The oncologic burden of hepatitis C virus infection: A clinical perspective.
  4. Aging impairs fibrosis-4 index after sustained virologic response by direct-acting antivirals in chronic hepatitis C infection.
  5. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
  6. Memory-like HCV-specific CD8<sup>+</sup> T cells retain a molecular scar after cure of chronic HCV infection.
  7. Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients.
  8. Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents.
  9. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection.
  10. Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus.